RAPTOR PHARMACEUTICALS CORP. (RPTP) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 487 transactions totaling $49.8M, demonstrating a bearish sentiment with -$28.0M in net insider flow. The most recent transaction on Oct 25, 2016 involved a transaction of 23,781 shares valued at $214.0K.
No significant insider buying has been recorded for RPTP in the recent period.
No significant insider selling has been recorded for RPTP in the recent period.
Based on recent SEC filings, insider sentiment for RPTP is bearish with an Insider Alignment Score of 22/100 and a net flow of -$28.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at RAPTOR PHARMACEUTICALS CORP. (RPTP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading RPTP stock, having executed 487 transactions in the past 90 days. The most active insider is Trading Segregated Portfolio Hyperion (Executive), who has made 94 transactions totaling $33.3M.
Get notified when executives and directors at RPTP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 25, 2016 | R. Polu Krishna | Executive | Disposition | 23,781 | $9.00 | $214.0K | |
| Oct 25, 2016 | M. Starr Christopher | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 25, 2016 | L. Franklin Richard | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 25, 2016 | Keltner Llew | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 25, 2016 | Smith Julie | Executive | Disposition | 64,179 | $9.00 | $577.6K | Large |
| Oct 25, 2016 | Anderson Raymond | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 25, 2016 | Gregg Lapointe Anthony | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 25, 2016 | C. Gould Ashley | Executive | Disposition | 36,690 | $9.00 | $330.2K | |
| Oct 25, 2016 | P. Smith Michael | Executive | Disposition | 22,607 | $9.00 | $203.5K | |
| Oct 25, 2016 | Happel David | Executive | Disposition | 28,939 | $9.00 | $260.5K | |
| Oct 25, 2016 | Gemayel Georges | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 25, 2016 | Louise Bruhn Suzanne | Executive | Disposition | 8,330 | $9.00 | $75.0K | |
| Oct 24, 2016 | M. Starr Christopher | Executive | Tender | 706,065 | $9.00 | $6.4M | Large |
| Oct 24, 2016 | L. Franklin Richard | Executive | Tender | 6,695 | $9.00 | $60.3K | |
| Oct 24, 2016 | Keltner Llew | Executive | Tender | 6,695 | $9.00 | $60.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 242 | $38.9M | 61.1% |
Purchase(P) | 49 | $10.9M | 17.1% |
Tender(U) | 10 | $7.6M | 11.9% |
Exercise(M) | 136 | $4.1M | 6.4% |
Disposition(D) | 12 | $2.1M | 3.3% |
Exercise (Options)(X) | 1 | $93.6K | 0.1% |
Payment(F) | 2 | $20.8K | 0.0% |
Award(A) | 28 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Other(J) | 6 | $0 | 0.0% |
Insider selling pressure at RAPTOR PHARMACEUTICALS CORP. has increased, with 21 insiders executing 487 transactions across all time. Total sales of $38.9M significantly outpace purchases of $10.9M, resulting in a net outflow of $28.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.